Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1996-7-25
pubmed:abstractText
To evaluate an intensive concomitant chemoradiotherapy protocol of conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion fluorouracil (5-FU) in unresectable, locally advanced squamous cell carcinoma of the head and neck (SCCHN).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1192-200
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8648374-Adult, pubmed-meshheading:8648374-Aged, pubmed-meshheading:8648374-Antimetabolites, Antineoplastic, pubmed-meshheading:8648374-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8648374-Carcinoma, Squamous Cell, pubmed-meshheading:8648374-Chemotherapy, Adjuvant, pubmed-meshheading:8648374-Cisplatin, pubmed-meshheading:8648374-Feasibility Studies, pubmed-meshheading:8648374-Female, pubmed-meshheading:8648374-Fluorouracil, pubmed-meshheading:8648374-Head and Neck Neoplasms, pubmed-meshheading:8648374-Humans, pubmed-meshheading:8648374-Infusions, Intravenous, pubmed-meshheading:8648374-Male, pubmed-meshheading:8648374-Middle Aged, pubmed-meshheading:8648374-Neoplasm Staging, pubmed-meshheading:8648374-Patient Compliance, pubmed-meshheading:8648374-Prognosis, pubmed-meshheading:8648374-Radiotherapy, Adjuvant, pubmed-meshheading:8648374-Risk Factors, pubmed-meshheading:8648374-Survival Analysis, pubmed-meshheading:8648374-Treatment Outcome
pubmed:year
1996
pubmed:articleTitle
Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.
pubmed:affiliation
Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II